Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Bullboard Posts
Post by FactFinder1994on Dec 06, 2015 2:59pm
163 Views
Post# 24359323

Preserving Organs via PMX treatment

Preserving Organs via PMX treatment Organ Preservation is why so many Doctors choose to drive Volvo's. They may survive an incident without the safety of a Volvo, but the quality of life afterward may not be all that desirable. Limiting the amount of damage to organs during gram negative sepsis is a key benefit of quick endotoxin removal from the bloodstream and it not only helps in the immediate crisis but also during and after recovery, assuming survival. So, this goes way beyond safety, life or death. It is a quality and $$ after survival save story too. Given the information/data accumulated over the last two decades, American's too should soon be able to benefit from this safe and beneficial ADDITION to the current standard of care. Why not increase the chances of survival and at the same time potentially preserve organs for a better quality of life after sepsis? With the guidance of the EAA, patient selection for PMX has been made efficient and cost effective. In the New Year the Spectral Pump will add an element of convenience too. Better survival rates along with higher quality of life for those that qualify to receive PMX and ultimately delivering a net cost saving to medical system is a huge story that should receive much more attention IMHO...
Bullboard Posts